Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
(NY:
GSK
)
33.60
+0.17 (+0.51%)
Official Closing Price
Updated: 7:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,813,074
Open
33.13
Bid (Size)
33.34 (1)
Ask (Size)
34.00 (1)
Prev. Close
33.43
Today's Range
33.04 - 33.87
52wk Range
32.83 - 45.92
Shares Outstanding
5,385,189,617
Dividend Yield
4.60%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
December 19, 2024
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.
Via
Benzinga
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
December 18, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:PFE),(NYSE:GSK),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
Performance
YTD
-10.42%
-10.42%
1 Month
-0.30%
-0.30%
3 Month
-17.77%
-17.77%
6 Month
-17.14%
-17.14%
1 Year
-9.16%
-9.16%
More News
Read More
GSK Stock Crumbles As Vaccine Sales Plummet And Miss Expectations
October 30, 2024
Via
Investor's Business Daily
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
December 18, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
December 18, 2024
Via
Investor's Business Daily
AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?
December 17, 2024
Via
Investor's Business Daily
What's Going On Moderna Stock On Monday?
December 16, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children
December 13, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Product Safety
Bird Flu Spreads To Cats, Possibly Horses As Officials Signal No Plans To Authorize Vaccination
December 13, 2024
Via
Benzinga
United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis
December 13, 2024
Via
Benzinga
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
December 12, 2024
Via
Benzinga
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
December 10, 2024
Via
Benzinga
Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse
December 09, 2024
From
GSK plc
Via
Business Wire
Oracle, Vertiv And A Health Care Stock On CNBC's 'Final Trades'
December 09, 2024
Via
Benzinga
Bird Flu Found In Raw Milk Leads To Recall In California
November 26, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
November 26, 2024
Via
Benzinga
Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?
November 20, 2024
Via
Benzinga
GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
November 19, 2024
Via
Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
Via
Benzinga
Exposures
Product Safety
GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
November 14, 2024
Via
Benzinga
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
November 13, 2024
Via
Benzinga
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
November 12, 2024
Via
Benzinga
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
November 07, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing?
November 07, 2024
Via
Investor's Business Daily
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
November 01, 2024
Via
Investor's Business Daily
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.